{"batchcomplete":"","continue":{"lecontinue":"20261106070512|853794","continue":"-||"},"query":{"logevents":[{"logid":853804,"ns":6,"title":"File:Abid Qurrat-Ul-Ain circle.png","pageid":0,"logpage":325388,"params":{},"type":"delete","action":"delete","user":"Gerald Chi","timestamp":"2026-11-09T06:19:42Z","comment":"User request"},{"logid":853803,"ns":0,"title":"Autoimmune Encephalitis future or investigational therapies","pageid":337728,"logpage":337728,"revid":1747091,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T12:32:09Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] research is evaluating targeted immune treatments for patients with incomplete response to conventional therapy. Investigational treatment should be distinguished from established first- and second-line approaches. Published recommendations support specialist reassessment before rescue treatment because persistent disability does not necessarily...\""},{"logid":853802,"ns":0,"title":"Autoimmune Encephalitis cost-effectiveness of therapy","pageid":337727,"logpage":337727,"revid":1747090,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T12:28:06Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] can impose substantial hospital and long-term care costs. Published economic evidence includes resource-use studies and diagnostic-screening models, but these do not establish a universally most cost-effective immunotherapy.<ref name=\"Keller2026\">Keller N, Bertram D, Hamer H, et al. [https://pubmed.ncbi.nlm.nih.gov/41998723/ Hospital resource use...\""},{"logid":853801,"ns":0,"title":"Autoimmune Encephalitis secondary prevention","pageid":337726,"logpage":337726,"revid":1747089,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T12:17:41Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] secondary prevention focuses on reducing relapse risk and recognizing recurrent disease after an initial episode. Follow-up and preventive treatment should reflect disease subtype, previous attacks, severity, and treatment risks. Long-term immunosuppression is not routinely recommended for every patient after a first presentation.<ref name=\"Hahn2...\""},{"logid":853800,"ns":0,"title":"Autoimmune Encephalitis primary prevention","pageid":337725,"logpage":337725,"revid":1747088,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T12:12:18Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] has no established disease-specific strategy that reliably prevents a first episode. Primary prevention concerns preventing disease before it develops; treatment of established encephalitis and prevention of relapse are separate issues. Expert information from Mayo Clinic emphasizes that consistent preventive measures for autoimmune causes of enc...\""},{"logid":853799,"ns":0,"title":"Autoimmune Encephalitis rehabilitation","pageid":337724,"logpage":337724,"revid":1747086,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T12:06:45Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] rehabilitation addresses physical, cognitive, communication, psychological, and participation difficulties after the acute illness. The 2024 Canadian consensus recommends screening for residual neuropsychiatric impairment and offering psychiatric care and neuropsychological rehabilitation when appropriate.<ref name=\"Hahn2024\">Hahn C, Budhram A, A...\""},{"logid":853798,"ns":0,"title":"Autoimmune Encephalitis pediatric treatment considerations","pageid":337723,"logpage":337723,"revid":1747085,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T11:57:20Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] treatment in children requires pediatric neurology expertise, developmentally appropriate assessment, and individualized immunotherapy. The international pediatric treatment consensus specifically addresses N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis; its recommendations should not automatically be applied to every childhood infla...\""},{"logid":853797,"ns":0,"title":"Autoimmune Encephalitis surgery","pageid":337722,"logpage":337722,"revid":1747074,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T07:44:27Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] is primarily treated medically, but removal of an associated tumor can be an important component of treatment. Surgery is directed at the relevant neoplasm or a specific complication, rather than routine removal of brain tissue.<ref name=\"Abboud2021\">Abboud H, Probasco JC, Irani S, et al. [https://pubmed.ncbi.nlm.nih.gov/33649022/ Autoimmune ence...\""},{"logid":853796,"ns":0,"title":"Autoimmune Encephalitis interventions","pageid":337721,"logpage":337721,"revid":1747073,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T07:33:38Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] may require therapeutic plasma exchange and procedures to manage respiratory failure, severe autonomic dysfunction, nutritional difficulties, or refractory catatonia. Interventions are selected according to disease severity and complications and should accompany appropriate immunotherapy and treatment of an associated neoplasm.<ref name=\"AbboudAc...\""},{"logid":853795,"ns":0,"title":"Autoimmune Encephalitis symptomatic and supportive therapy","pageid":337720,"logpage":337720,"revid":1747072,"params":{},"type":"create","action":"create","user":"Julinka Auta Fernandes","timestamp":"2026-11-06T07:25:01Z","comment":"Created page with \"__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}}  ==Overview== [[Autoimmune Encephalitis|Autoimmune encephalitis]] requires symptomatic and supportive treatment alongside immunotherapy and treatment of an associated tumor. Care aims to control seizures and distress, prevent complications, and restore function. Symptomatic improvement alone does not establish that inflammation has resolved.<ref name=\"AbboudLong2021\">Abboud H, Probasco J, Irani SR, et al. [http...\""}]}}